Nanhua Bio (China) Buy Hold or Sell Recommendation
| 000504 Stock | 10.23 0.02 0.20% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Nanhua Bio Medicine is 'Strong Hold'. Macroaxis provides Nanhua Bio buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 000504 positions.
Check out Nanhua Bio Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Nanhua and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Nanhua Bio Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Nanhua |
Execute Nanhua Bio Buy or Sell Advice
The Nanhua recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Nanhua Bio Medicine. Macroaxis does not own or have any residual interests in Nanhua Bio Medicine or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Nanhua Bio's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Insignificant | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Nanhua Bio Trading Alerts and Improvement Suggestions
| The company reported the revenue of 136.79 M. Net Loss for the year was (28.17 M) with profit before overhead, payroll, taxes, and interest of 84.43 M. | |
| About 13.0% of the company shares are owned by insiders or employees |
Nanhua Bio Returns Distribution Density
The distribution of Nanhua Bio's historical returns is an attempt to chart the uncertainty of Nanhua Bio's future price movements. The chart of the probability distribution of Nanhua Bio daily returns describes the distribution of returns around its average expected value. We use Nanhua Bio Medicine price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Nanhua Bio returns is essential to provide solid investment advice for Nanhua Bio.
| Mean Return | -0.02 | Value At Risk | -3.77 | Potential Upside | 3.97 | Standard Deviation | 2.79 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Nanhua Bio historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Nanhua Bio Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | 3.7M | 4.3M | 4.8M | (6.2M) | (5.6M) | (5.3M) | |
| Dividends Paid | 1.1M | 2.1M | 2.4M | 2.3M | 2.1M | 2.0M | |
| Capital Expenditures | 4.5M | 32.0M | 16.9M | 5.9M | 6.8M | 6.1M | |
| Net Income | 8.2M | (19.1M) | (12.7M) | (28.2M) | (25.4M) | (24.1M) | |
| Net Borrowings | (39M) | 192.3M | 19.9M | (73.0M) | (65.7M) | (62.4M) | |
| Change To Netincome | (21.3M) | 12.7M | 34.3M | 22.2M | 25.5M | 26.8M | |
| Investments | 12.5M | 167.0 | 494.6K | 12.8M | 11.5M | 7.5M | |
| Change In Cash | (2.4M) | 86.0M | 65.1M | 275.7M | 317.0M | 332.9M | |
| Depreciation | 3.4M | 6.9M | 6.2M | 6.3M | 7.3M | 5.4M | |
| End Period Cash Flow | 67.0M | 153.0M | 218.1M | 493.8M | 567.8M | 596.2M | |
| Free Cash Flow | (211.7M) | 75.1M | 149.4M | 30.4M | 34.9M | 36.7M | |
| Other Non Cash Items | 4.5M | 20.8M | 21.6M | 20.2M | 23.3M | 18.1M |
Nanhua Bio Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Nanhua Bio or Media sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Nanhua Bio's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Nanhua stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | 0.57 | |
σ | Overall volatility | 2.90 | |
Ir | Information ratio | 0.03 |
Nanhua Bio Volatility Alert
Nanhua Bio Medicine exhibits very low volatility with skewness of 0.59 and kurtosis of 3.06. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Nanhua Bio's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Nanhua Bio's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Nanhua Bio Fundamentals Vs Peers
Comparing Nanhua Bio's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Nanhua Bio's direct or indirect competition across all of the common fundamentals between Nanhua Bio and the related equities. This way, we can detect undervalued stocks with similar characteristics as Nanhua Bio or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Nanhua Bio's fundamental indicators could also be used in its relative valuation, which is a method of valuing Nanhua Bio by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Nanhua Bio to competition |
| Fundamentals | Nanhua Bio | Peer Average |
| Return On Equity | -0.31 | -0.31 |
| Return On Asset | -0.0455 | -0.14 |
| Profit Margin | (0.30) % | (1.27) % |
| Operating Margin | 0.01 % | (5.51) % |
| Current Valuation | 3.09 B | 16.62 B |
| Shares Outstanding | 330.02 M | 571.82 M |
| Shares Owned By Insiders | 13.22 % | 10.09 % |
| Shares Owned By Institutions | 40.52 % | 39.21 % |
| Price To Book | 13.60 X | 9.51 X |
| Price To Sales | 26.78 X | 11.42 X |
| Revenue | 136.79 M | 9.43 B |
| Gross Profit | 84.43 M | 27.38 B |
| EBITDA | (38.19 M) | 3.9 B |
| Net Income | (28.17 M) | 570.98 M |
| Total Debt | 28.12 M | 5.32 B |
| Book Value Per Share | 0.75 X | 1.93 K |
| Cash Flow From Operations | 36.28 M | 971.22 M |
| Earnings Per Share | (0.12) X | 3.12 X |
| Beta | 0.71 | -0.15 |
| Market Capitalization | 3.38 B | 19.03 B |
| Total Asset | 771.38 M | 29.47 B |
| Retained Earnings | (531.1 M) | 9.33 B |
| Working Capital | 202.45 M | 1.48 B |
| Net Asset | 771.38 M |
Nanhua Bio Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Nanhua . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 160509.0 | |||
| Daily Balance Of Power | (0.06) | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 10.21 | |||
| Day Typical Price | 10.22 | |||
| Price Action Indicator | 0.01 | |||
| Period Momentum Indicator | (0.02) |
About Nanhua Bio Buy or Sell Advice
When is the right time to buy or sell Nanhua Bio Medicine? Buying financial instruments such as Nanhua Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Nanhua Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Shipbuilding Railroad Equipment Thematic Idea Now
Shipbuilding Railroad Equipment
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipbuilding Railroad Equipment theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipbuilding Railroad Equipment Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Nanhua Stock
Nanhua Bio financial ratios help investors to determine whether Nanhua Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nanhua with respect to the benefits of owning Nanhua Bio security.